These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1734913)
21. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis. Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102 [TBL] [Abstract][Full Text] [Related]
22. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. Phadke K; Carlson DG; Gitter BD; Butler LD J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226 [TBL] [Abstract][Full Text] [Related]
23. Human secreted stabilin-1-interacting chitinase-like protein aggravates the inflammation associated with rheumatoid arthritis and is a potential macrophage inflammatory regulator in rodents. Xiao W; Meng G; Zhao Y; Yuan H; Li T; Peng Y; Zhao Y; Luo M; Zhao W; Li Z; Zheng X Arthritis Rheumatol; 2014 May; 66(5):1141-52. PubMed ID: 24470346 [TBL] [Abstract][Full Text] [Related]
24. Enhanced expression of interleukin 6 in rat and murine arthritis models. Sugita T; Furukawa O; Ueno M; Murakami T; Takata I; Tosa T Int J Immunopharmacol; 1993 May; 15(4):469-76. PubMed ID: 8365823 [TBL] [Abstract][Full Text] [Related]
25. Detection of arthritogenic factor in adjuvant arthritis. Helfgott SM; Kieval RI; Breedveld FC; Brahn E; Young CT; Dynesius-Trentham R; Trentham DE J Immunol; 1988 Mar; 140(6):1838-43. PubMed ID: 3257989 [TBL] [Abstract][Full Text] [Related]
26. Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. Cremer MA; Stuart JM; Townes AS; Kang AH J Immunol; 1980 Jun; 124(6):2912-8. PubMed ID: 6989910 [TBL] [Abstract][Full Text] [Related]
27. [The effect of the type II collagen protein from Zaocys on cytokines production by synoviocytes in rats with adjuvant arthritis]. Pang J; Li J; Wu XH; Wu HY Zhong Yao Cai; 2009 Apr; 32(4):556-60. PubMed ID: 19645241 [TBL] [Abstract][Full Text] [Related]
28. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Mauri C; Williams RO; Walmsley M; Feldmann M Eur J Immunol; 1996 Jul; 26(7):1511-8. PubMed ID: 8766554 [TBL] [Abstract][Full Text] [Related]
29. Endosteal new bone formation in the long bones of adjuvant treated rats. Tomoda K; Kitaoka M; Iyama K; Usuku G Pathol Res Pract; 1986 Jun; 181(3):331-8. PubMed ID: 3489227 [TBL] [Abstract][Full Text] [Related]
30. Influence of bioflavonoids on the collagen metabolism in rats with adjuvant induced arthritis. Rao CN; Rao VH; Steinmann B Ital J Biochem; 1981; 30(1):54-62. PubMed ID: 7251341 [TBL] [Abstract][Full Text] [Related]
31. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Carlson BC; Jansson AM; Larsson A; Bucht A; Lorentzen JC Am J Pathol; 2000 Jun; 156(6):2057-65. PubMed ID: 10854227 [TBL] [Abstract][Full Text] [Related]
32. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510 [TBL] [Abstract][Full Text] [Related]
33. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Nishikawa M; Myoui A; Tomita T; Takahi K; Nampei A; Yoshikawa H Arthritis Rheum; 2003 Sep; 48(9):2670-81. PubMed ID: 13130488 [TBL] [Abstract][Full Text] [Related]
34. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Yamanishi Y; Boyle DL; Pinkoski MJ; Mahboubi A; Lin T; Han Z; Zvaifler NJ; Green DR; Firestein GS Am J Pathol; 2002 Jan; 160(1):123-30. PubMed ID: 11786406 [TBL] [Abstract][Full Text] [Related]
35. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; HeinegÄrd D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of cartilage degradation in rat collagen-induced arthritis but not adjuvant arthritis by the neutrophil elastase inhibitor MDL 101,146. Janusz MJ; Durham SL Inflamm Res; 1997 Dec; 46(12):503-8. PubMed ID: 9459081 [TBL] [Abstract][Full Text] [Related]
37. The release of interleukin-1-like activity by macrophages in two models of immunological inflammation in the rat. Becherucci C; Donati D; Perretti M; Parente L Agents Actions; 1989 Nov; 28(3-4):243-7. PubMed ID: 2556898 [TBL] [Abstract][Full Text] [Related]
38. Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis. Cremer MA; Townes AS; Kang AH Clin Exp Immunol; 1990 Nov; 82(2):307-12. PubMed ID: 2242611 [TBL] [Abstract][Full Text] [Related]
39. Influence of prednisolone & L-thyroxine on the changes in collagen crosslinking in rats with adjuvant-induced arthritis. Kuberasampath T; Bose SM Indian J Biochem Biophys; 1980 Apr; 17(2):99-103. PubMed ID: 7450800 [No Abstract] [Full Text] [Related]
40. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation. Magari K; Miyata S; Ohkubo Y; Mutoh S Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]